GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 26 filers reported holding GALMED PHARMACEUTICALS LTD in Q2 2021. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $214 | -14.4% | 500 | 0.0% | 0.00% | – |
| Q4 2022 | $250 | – | 500 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 500 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 500 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | -100.0% |
| Q3 2020 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $2,000 | -33.3% | 500 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $3,000 | +50.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $2,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,878,508 | $12,830,000 | 1.68% |
| Knoll Capital Management, LLC | 210,000 | $1,434,000 | 1.63% |
| Vivo Capital, LLC | 971,337 | $6,634,000 | 0.85% |
| P.A.W. CAPITAL CORP | 90,000 | $615,000 | 0.77% |
| 683 Capital Management, LLC | 1,350,000 | $9,221,000 | 0.56% |
| Ibex Investors LLC | 500,000 | $3,415,000 | 0.56% |
| MEITAV INVESTMENT HOUSE LTD | 653,667 | $4,465,000 | 0.28% |
| FIRST MIDWEST BANK TRUST DIVISION | 214,872 | $1,468,000 | 0.22% |
| Nantahala Capital Management | 834,401 | $5,699,000 | 0.18% |
| PREMIER ASSET MANAGEMENT LLC | 73,950 | $505,000 | 0.14% |